Singh Shawn
VistaGen Therapeutics, Inc. · President and CEO
Singh Shawn is listed in public filings as director, officer: President and CEO. This Singh Shawn insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include VistaGen Therapeutics, Inc. (VTGN). Investors use Singh Shawn's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.0k3.7k shares | Grant / ExerciseApr 7, 2026 | $2.0K3.7k shares | $0.5358 | -- | |
| $38k71.3k shares | Grant / ExerciseApr 7, 2026 | $38.2K71.3k shares | $0.5358 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $31k18k shares | Grant / ExerciseJun 30, 2025 | $12.8K7.5k shares | $1.70 | -- | |
| $588k300k shares | Grant / ExerciseJun 23, 2025 | $588.0K300k shares | $1.96 | -- | |
| $31k10.5k shares | Grant / ExerciseJun 28, 2024 | $14.4K4.9k shares | $2.96 | -- | |
| $1.6M500k shares | Grant / ExerciseJun 24, 2024 | $1.6M500k shares | $3.23 | -- |